バイオロジカルインプラント市場 - 世界の産業規模、シェア、動向、機会、予測：製品別、用途別、地域別、競合、2018年～2028年

バイオロジカルインプラントの世界市場は、2022年に78億2,000万米ドルと評価され、2028年までのCAGRは6.30%で、予測期間には目覚ましい成長が見込まれています。

バイオロジカルインプラントは、生体インプラントまたは生物学的由来インプラントとしても知られ、人体内で損傷したり失われたりした生物学的構造を置換または支持するために使用される医療機器または組織です。これらのインプラントは、天然組織、合成生体材料、あるいはその両方の組み合わせなど、さまざまな材料から作成することができます。バイオロジカルインプラントの主な目的は、身体の自然治癒プロセスを促進し、生理的機能を回復または改善することです。バイオロジカルインプラントは、生体適合性を持つように設計されています。つまり、生体適合性が高く、身体への耐性が高く、不利な免疫反応や拒絶反応を引き起こさないということです。このため、インプラントは周囲の組織と効果的に統合されます。バイオロジカルインプラントの中には、組織の再生を促すことを目的としたものもあります。バイオロジカルインプラントは、体の細胞が成長するための足場を提供し、損傷したり失われたりした組織の置換を促進します。これは、骨移植や組織工学的臓器などの用途で一般的です。バイオロジカルインプラントは、意図された目的に応じて、一時的なものと永続的なものがあります。一時的なインプラントは、決められた期間、特定の機能を果たすように設計されており、徐々に吸収されたり、自然な組織に置き換わったりします。一方、恒久的なインプラントは、長期的なソリューションを提供することを目的としています。

生体材料、3Dプリンティング、再生医療の市場開拓により、より高度で効果的なバイオロジカルインプラントが開発され、市場成長を牽引しています。患者の意識の高まりと生活の質の向上への願望が、特に形成外科や再建外科などの分野におけるバイオロジカルインプラントの需要増につながっています。患者の転帰と経験を改善することに重点を置いた患者中心の医療へのシフトが、革新的なバイオロジカルインプラントの使用をより重視することにつながっています。世界の人口動態の高齢化は重要な推進力です。人口の高齢化に伴い、特に整形外科や心臓血管のような分野では、加齢に関連した健康問題によりバイオロジカルインプラントの需要が増加しています。

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のバイオロジカルインプラント市場展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 製品別（自家移植片、同種移植片、異種移植片）
  • 用途別（心臓血管インプラント、整形外科インプラント、その他軟組織インプラント）
  • 地域別
  • 企業別（2022年）
• 市場マップ

第6章 アジア太平洋のバイオロジカルインプラント市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 製品別
  • 用途別
  • 国別
• アジア太平洋：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第7章 欧州のバイオロジカルインプラント市場展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 製品別
  • 用途別
  • 国別
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第8章 北米のバイオロジカルインプラント市場展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 製品別
  • 用途別
  • 国別
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第9章 南米のバイオロジカルインプラント市場展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 製品別
  • 用途別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのバイオロジカルインプラント市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 製品別
  • 用途別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

第13章 世界のバイオロジカルインプラント市場：SWOT分析

第14章 ポーターのファイブフォース分析

第15章 PESTLE分析

第16章 競合情勢

• Integra LifeSciences
• NuVasive, Inc.
• Edwards Lifesciences Corporation
• Stryker Corporation
• LifeCell International Pvt. Ltd.
• Medtronic Plc.
• Osteotec Limited
• BioPolymer GmbH & Co KG
• Johnson & Johnson
• Baxter International Inc.

第17章 戦略的提言

第18章 調査会社・免責事項

Global Biological Implants Market was valued at USD 7.82 billion in 2022 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 6.30% through 2028. Biological implants, also known as bio-implants or biologically derived implants, are medical devices or tissues that are used to replace or support damaged or lost biological structures within the human body. These implants can be created from a variety of materials, including natural tissues, synthetic biomaterials, or a combination of both. The primary goal of biological implants is to enhance the body's natural healing processes and restore or improve physiological functions. Biological implants are designed to be biocompatible, meaning they are well-tolerated by the body and do not trigger an adverse immune response or rejection. This ensures that the implant integrates effectively with the surrounding tissues. Some biological implants are intended to stimulate tissue regeneration. They provide a scaffold for the body's cells to grow into, promoting the replacement of damaged or lost tissue. This is common in applications like bone grafts and tissue-engineered organs. Biological implants can be temporary or permanent, depending on the intended purpose. Temporary implants are designed to fulfill a specific function for a defined period and are gradually absorbed or replaced by natural tissue. Permanent implants, on the other hand, are meant to provide a long-lasting solution.

Advances in biomaterials, 3D printing, and regenerative medicine have led to the development of more sophisticated and effective biological implants, driving market growth. Growing patient awareness and the desire for improved quality of life have led to increased demand for biological implants, particularly in fields like plastic and reconstructive surgery. The shift toward patient-centric care, with a focus on improving patient outcomes and experiences, has led to a greater emphasis on the use of innovative biological implants. The global aging demographic is a significant driver. As the population ages, the demand for biological implants, especially in areas like orthopedics and cardiovascular health, increases due to age-related health issues.

Key Market Drivers

Technological Advancements

The development of advanced biomaterials, such as biodegradable polymers, bioactive ceramics, and nanomaterials, has significantly improved the biocompatibility and longevity of biological implants. These materials closely mimic the properties of natural tissues, reducing the risk of adverse reactions and implant failure. 3D printing technology has revolutionized implant manufacturing. It enables the creation of patient-specific implants, tailored to an individual's anatomy, which improves the fit and functionality of the implant. This technology is widely used in orthopedics, craniofacial surgery, and dental implants. Advances in regenerative medicine have led to the development of tissue-engineered implants. These implants promote the regeneration of damaged or lost tissues by using stem cells, growth factors, and scaffolds. They are particularly promising in areas like organ transplantation and cartilage repair. Nanotechnology has been applied to enhance the surface properties of implants. Nanostructured surfaces can promote better cell adhesion, faster tissue integration, and reduced inflammation, resulting in improved implant performance.

Implants are now coated with biological materials, such as proteins, peptides, and growth factors, to improve tissue integration and reduce the risk of implant rejection. These coatings encourage the host cells to adhere to the implant's surface. Some implants, like pacemakers and glucose sensors, now incorporate wireless technology for real-time monitoring. This allows healthcare professionals to remotely assess the implant's performance and the patient's health status, improving patient care and reducing the need for frequent in-person check-ups. Smart implants with embedded sensors and microelectronics can collect data, monitor conditions, and even deliver targeted therapies. These are used in various medical fields, such as neurology and orthopedics. Implants with biomechanical sensors can provide real-time feedback on the performance of artificial joints and limbs, aiding in the optimization of prosthetic function and comfort.

Implants that slowly release medications or growth factors into the surrounding tissue are used to improve healing and reduce complications. For example, drug-eluting stents are used in cardiology to prevent restenosis. Precise implant placement is crucial for success. Surgical navigation systems and robotics assist surgeons in accurately positioning implants during procedures, reducing the risk of errors and complications. The emerging field of bioprinting involves the creation of complex, functional tissues and organs using 3D printing technology. While still in the experimental phase, it holds the potential for creating custom biological implants. Advances in medical imaging and computer-aided design have made it possible to create personalized implants that precisely match a patient's anatomy. This reduces the risk of complications and improves patient outcomes. This factor will help in the development of the Global Biological Implants Market.

Increased Awareness and Patient Demand

Increased awareness is often a result of educational campaigns, information dissemination, and improved patient access to healthcare resources. As patients become more informed about medical conditions and available treatment options, they are better equipped to discuss these options with their healthcare providers. The media, including the internet, television, and social media, has played a significant role in raising awareness about various medical conditions and the potential solutions, including biological implants. Patients can access a wealth of information about implant procedures, success stories, and patient testimonials, which can influence their decisions. High-profile individuals who have openly discussed their experiences with biological implants, such as breast augmentation or cosmetic surgery, have contributed to increased awareness. Their openness often sparks discussions and encourages others to explore these options. Patient advocacy groups and organizations related to specific medical conditions often raise awareness about the benefits of biological implants as part of their efforts to improve the lives of those affected by these conditions.

Informed patients are more likely to engage in discussions with their healthcare providers regarding the potential use of biological implants. As patients become more knowledgeable, these conversations can lead to greater demand for implant procedures. Patients are increasingly focused on their quality of life and well-being. Many biological implants, such as orthopedic implants, dental implants, and cosmetic implants, offer the potential to enhance a patient's overall quality of life by improving physical function or appearance. Patients are becoming more aware of the availability of customized or patient-specific biological implants, which can provide a tailored solution to address their unique medical needs. In some societies, cultural or social factors may influence patient preferences and choices regarding biological implants. This can include beauty ideals, body image, and societal norms.

Satisfied patients who have undergone successful implant procedures often share their experiences with family and friends, leading to word-of-mouth referrals. This informal communication can drive patient demand. As biological implants become more common and accepted, the stigma associated with certain procedures, such as cosmetic surgery or dental implants, has decreased. This can encourage more patients to consider these options. The shift toward patient-centric healthcare encourages providers to consider patient preferences and values. This approach can lead to a greater emphasis on shared decision-making, where patients actively participate in the choice of treatment, including biological implants. This factor will pace up the demand of the Global Biological Implants Market.

Increasing Aging Population

With increasing age, individuals are more likely to develop age-related health issues, such as osteoarthritis, osteoporosis, cardiovascular diseases, and degenerative joint disorders. Many of these conditions necessitate the use of biological implants for treatment and management. The elderly are more prone to musculoskeletal problems, including joint degeneration and fractures. Orthopedic implants, such as hip and knee replacements, are commonly required to restore mobility and reduce pain in older individuals. As people age, they are more likely to experience tooth loss or dental issues. Dental implants are frequently used to replace missing teeth and restore oral function in older adults. Aging can lead to changes in physical appearance and the development of skin laxity. Many elderly individuals seek cosmetic and reconstructive procedures, such as facelifts or eyelid surgery, which often involve biological implants like dermal fillers or facial implants.

The elderly population is at a higher risk of cardiovascular diseases. Biological implants like stents and valves are frequently used to manage and treat heart conditions in older patients. Age-related eye conditions, such as cataracts and glaucoma, often require the use of biological implants like intraocular lenses or drainage devices. Biological implants are also used in the development of durable medical equipment such as hearing aids, which are commonly required as people age and experience hearing loss. Biological implants can significantly improve the quality of life for older individuals by addressing health conditions and enhancing functional abilities. This drives demand among the aging population who are seeking to maintain an active and independent lifestyle.

As people live longer and lead more active lives in their senior years, the demand for implants that can help maintain mobility and well-being increases. Advances in implant materials and surgical techniques have made these procedures more accessible and less invasive, making them suitable for older patients. Improved access to healthcare services has allowed more elderly individuals to seek medical treatment, including the use of biological implants, to manage age-related conditions. The sheer number of older adults in the population is increasing globally. This demographic shift leads to a larger pool of potential implant recipients. This factor will accelerate the demand of the Global Biological Implants Market.

Key Market Challenges

Sustainability Concerns

The production and disposal of medical implants, especially those made from non-biodegradable materials, can have a significant environmental impact. This includes the use of resources, energy, and the generation of waste and greenhouse gas emissions. The implantation process and subsequent revisions can result in the generation of medical waste, which can be a concern in terms of proper disposal and its environmental consequences. The use of single-use implants can generate more waste and contribute to the disposal problem. Reusable or biodegradable options are often more sustainable. The sustainability of implant materials, such as metals, plastics, or biologics, may be questioned if they are sourced in environmentally harmful ways or if the materials themselves are not biodegradable. The manufacturing of implants, especially those that use rare or non-renewable resources, can lead to overuse and depletion of these resources. In many cases, there is a lack of efficient systems for recycling implant materials. This can result in the disposal of potentially valuable materials that could be repurposed. The manufacturing and sterilization processes for implants can be energy-intensive, contributing to a carbon footprint. Reducing energy consumption is a sustainability goal.

Market Access in Emerging Economies

Emerging economies may have complex and evolving regulatory systems for medical devices. Navigating these regulatory hurdles can be time-consuming and expensive for manufacturers seeking market approval for biological implants. Each country within an emerging economy may have its own unique regulatory requirements for medical devices, making it challenging for manufacturers to meet varying standards. Emerging economies may have limited healthcare infrastructure, including hospitals and clinics with the capabilities to perform implant procedures. This can affect the availability and accessibility of biological implant treatments. In some emerging economies, healthcare reimbursement systems may not fully cover the cost of biological implant procedures. This can impact patient affordability and the demand for such treatments. Economic factors, such as income levels and healthcare spending, can influence the adoption of biological implants. In emerging economies, affordability can be a significant barrier for many patients. The availability of skilled surgeons and healthcare professionals with expertise in implant procedures can be limited in some emerging economies, affecting the quality of care and patient outcomes. The healthcare systems in emerging economies can be fragmented, with a mix of public and private providers. This complexity can make it challenging for manufacturers to target the right audience and establish distribution networks.

Key Market Trends

Biological Scaffolds and Tissue Engineering

Biological scaffolds and tissue engineering are at the forefront of regenerative medicine, which focuses on repairing or replacing damaged or degenerated tissues and organs. These approaches aim to stimulate the body's natural regenerative processes, enhancing healing and restoring tissue functionality. Tissue engineering allows for the creation of patient-specific implants. This customization ensures that the implant closely matches the patient's anatomy, increasing the chances of a successful outcome. Biological scaffolds and tissue engineering are being explored in a wide range of medical applications, including orthopedics (bone and cartilage regeneration), cardiovascular (blood vessel repair), urology (bladder reconstruction), and plastic and reconstructive surgery. Advances in biomaterials, such as biodegradable polymers and hydrogels, play a critical role in tissue engineering. These materials provide a biocompatible and supportive environment for cell growth and tissue regeneration. Stem cell research is closely integrated with tissue engineering. Stem cells can be manipulated and guided to differentiate into specific cell types, making them a valuable tool in regenerating damaged tissues. Biological scaffolds, often derived from natural tissues or engineered materials, serve as templates for tissue regeneration. They provide the structure and cues for cells to grow and differentiate.

Segmental Insights

Product Insights

In 2022, the Global Biological Implants Market largest share was held by xenografts segment and is predicted to continue expanding over the coming years. Xenotransplantation, the use of animal-derived tissues or organs in humans, has seen advancements in recent years. This has led to increased interest in xenografts as a viable option for various medical applications, including implants. The shortage of human donor organs for transplantation has prompted researchers and medical professionals to explore xenotransplantation as a potential solution to meet the high demand for organs. Regulatory agencies may have approved xenografts for a broader range of clinical applications, making them more accessible to healthcare providers and patients. Improved understanding of immunology and genetic engineering has led to the development of xenografts with reduced risk of immune rejection in recipients. Advances in tissue engineering and the development of biomaterials have enabled the creation of xenografts that closely mimic human tissues, enhancing their functionality and biocompatibility.

Application Insights

In 2022, the Global Biological Implants Market largest share was held by Soft Tissue Implants segment and is predicted to continue expanding over the coming years. Soft tissue implants find applications in various medical specialties, including plastic surgery, reconstructive surgery, orthopedics, and cardiovascular surgery. This versatility allows them to address a broad spectrum of medical conditions, contributing to their widespread adoption. With the global population aging, there is an increasing demand for soft tissue implants, particularly in cosmetic and reconstructive procedures. Aging leads to issues like sagging skin and tissue loss, which are often addressed with soft tissue implants. Soft tissue implants are frequently used in cosmetic and reconstructive surgery. Procedures like breast augmentation, facelifts, and tissue reconstruction after trauma or cancer surgery rely on soft tissue implants to achieve desired results. Advances in biomaterials have led to the development of safer and more biocompatible soft tissue implants. These materials mimic natural tissues and minimize the risk of adverse reactions. The trend toward minimally invasive surgical techniques has led to increased use of soft tissue implants. Patients often prefer procedures that result in smaller incisions, reduced scarring, and quicker recovery times. Soft tissue implants have undergone rigorous testing and regulatory scrutiny to ensure safety and efficacy. This regulatory approval and the well-documented safety of these implants contribute to their popularity.

Regional Insights

The North America region dominates the Global Biological Implants Market in 2022. North America boasts a well-developed and advanced healthcare infrastructure. The region has state-of-the-art medical facilities, advanced diagnostic technologies, and a strong focus on research and development, which fosters innovation in the field of biological implants. The United States is known for its high healthcare expenditure. This high level of spending contributes to the adoption of the latest medical technologies, including biological implants, and fuels market growth. North America, especially the United States, has stringent but well-defined regulatory processes for medical devices. The FDA (U.S. Food and Drug Administration) ensures that medical devices meet rigorous safety and efficacy standards. This provides a level of confidence in the quality and safety of biological implants, attracting both domestic and international manufacturers to the market. North America is home to many leading medical research institutions, universities, and biotechnology companies. These entities drive innovation in the field of biological implants, leading to the development of cutting-edge products and technologies. North America has a relatively high prevalence of chronic diseases, such as diabetes, heart disease, and orthopedic conditions. These conditions often require the use of biological implants, contributing to market growth.

Key Market Players

Integra LifeSciences

NuVasive, Inc.

Edwards Lifesciences Corporation

Stryker

LifeCell International Pvt. Ltd.

Medtronic

Osteotec Limited

BioPolymer GmbH & Co KG

Johnson & Johnson

Baxter International Inc.

Report Scope:

In this report, the Global Biological Implants Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biological Implants Market, By Product:

• Autografts
• Allografts
• Xenografts

Biological Implants Market, By Application:

• Cardiovascular Implants
• Orthopedic Implants
• Others Soft Tissue Implants

Biological Implants Market, By region:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• South Korea
• Australia
• Japan
• Europe
• Germany
• France
• United Kingdom
• Spain
• Italy
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Biological Implants Market.

Available Customizations:

• Global Biological Implants Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biological Implants Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Autografts, Allografts, Xenografts)
  • 5.2.2. By Application (Cardiovascular Implants, Orthopedic Implants, others Soft Tissue Implants)
  • 5.2.3. By Region
  • 5.2.4. By Company (2022)
• 5.3. Market Map

6. Asia Pacific Biological Implants Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. Asia Pacific: Country Analysis
  • 6.3.1. China Biological Implants Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
  • 6.3.2. India Biological Implants Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
  • 6.3.3. Australia Biological Implants Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
  • 6.3.4. Japan Biological Implants Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Product
      • 6.3.4.2.2. By Application
  • 6.3.5. South Korea Biological Implants Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Product
      • 6.3.5.2.2. By Application

7. Europe Biological Implants Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Biological Implants Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
  • 7.3.2. Germany Biological Implants Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
  • 7.3.3. Spain Biological Implants Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Biological Implants Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
  • 7.3.5. United Kingdom Biological Implants Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application

8. North America Biological Implants Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Biological Implants Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
  • 8.3.2. Mexico Biological Implants Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
  • 8.3.3. Canada Biological Implants Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application

9. South America Biological Implants Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Biological Implants Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Biological Implants Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Biological Implants Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application

10. Middle East and Africa Biological Implants Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Biological Implants Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Biological Implants Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Biological Implants Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Biological Implants Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. PESTLE Analysis

16. Competitive Landscape

• 16.1. Integra LifeSciences
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (In case of listed companies)
  • 16.1.5. Recent Developments
  • 16.1.6. SWOT Analysis
• 16.2. NuVasive, Inc.
• 16.3. Edwards Lifesciences Corporation
• 16.4. Stryker Corporation
• 16.5. LifeCell International Pvt. Ltd.
• 16.6. Medtronic Plc.
• 16.7. Osteotec Limited
• 16.8. BioPolymer GmbH & Co KG
• 16.9. Johnson & Johnson
• 16.10. Baxter International Inc.

17. Strategic Recommendations

18. About Us & Disclaimer